Gennex Laboratories
13.49
-0.54(-3.85%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-3.85%
1M-10.72%
6M+3.45%
1Y-28.51%
5Y+228.22%
View Company Insightsright
Latest news about Gennex Laboratories
Gennex Laboratories Reports Robust Q1 Performance with 20% Revenue Growth Aug 14, 2025
Gennex Laboratories Limited announced its Q1 financial results, showing significant growth. Standalone revenue increased by 20.2% to Rs 2,564.00 lacs. Standalone net profit slightly decreased by 0.4% to Rs 414.95 lacs. Consolidated revenue grew by 20.7% to Rs 3,417.75 lacs, while consolidated net profit rose by 7.7% to Rs 501.64 lacs. The company's standalone EPS remained stable at Rs 0.18, while consolidated EPS improved to Rs 0.22. Paid-up equity share capital increased to Rs 2,314.48 lacs.